YOU ARE HERE:
Starting treatment news
page  of 14
 
Headline
Date
  Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
16.07.08
  Anti-HIV treatment as successful in South Africa as Switzerland - but starting treatment late is costing lives
09.07.08
  Kivexa restored to first-line status in final British guidelines - but with cautions
09.07.08
  'ART as prevention tool' policy announced for British Columbia
04.07.08
  Important changes to nevirapine dosing advice made by FDA
03.07.08
  Antiretroviral use increases survival sixfold in Thai patients with HIV and tuberculosis
27.06.08
  Atazanavir approved for first-line treatment in Europe
24.06.08
  Improvement in anaemia in majority of US patients after starting AZT reported in large review
24.06.08
  Boosted protease inhibitors have 60% lower risk of resistance compared with other classes
18.06.08
  Extensive resistance common in Nigerians failing antiretroviral therapy
05.06.08
  Arm of international once-daily treatment study halted
30.05.08
  BHIVA: Starting ART earlier has cost implications, public health benefits, says HPA
14.05.08
  BHIVA: Many patients and clinicians still need educating about the benefits of treatment
08.05.08
  BHIVA: One in 40 people presenting to A&E departments with ‘flu’ symptoms has HIV
30.04.08
  BHIVA: Current tests may miss a third of HIV resistance in treatment-naive
29.04.08
  Os benefícios de um início mais precoce do tratamento ARV superam o risco de toxicidades, revela o estudo SMART
28.04.08
  Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals
25.04.08
  Se asocian recuentos mayores de células CD4 a una tasa menor de enfermedades no relacionadas con VIH en personas que toman antirretrovirales
25.04.08
  BHIVA: No clinical difference seen in first-line treatment response between B and non-B subtypes
24.04.08
  Tropism test could show which patients would benefit from starting HIV treatment sooner
23.04.08

page  of 14